Korff Susanne, Enders-Gier Patricia, Uhlmann Lorenz, Aurich Matthias, Greiner Sebastian, Hirschberg Kristof, Katus Hugo A, Mereles Derliz
Department of Internal Medicine III, Cardiology, Angiology and Pneumology, Im Neuenheimer Feld 410, 69121, Heidelberg, Germany.
Institute of Medical Biometry and Informatics, University of Heidelberg, Heidelberg, Germany.
Int J Cardiovasc Imaging. 2018 Aug;34(8):1215-1225. doi: 10.1007/s10554-018-1340-2. Epub 2018 Mar 19.
Pulmonary hypertension is a marker of disease severity. Exercise Doppler echocardiography (EDE) has proven to be feasible and reliable to assess pulmonary pressure. Increase in systolic pulmonary artery pressure (sPAP) has diagnostic and prognostic value in controlled studies. However, its value when assessed during routine examination in patients with cardiopulmonary diseases and resting sPAP > 35 mmHg is not clearly defined. Clinical documentation and offline reevaluation of digitally stored EDE examinations of patients with appropriate clinical indications for EDE were analyzed. N = 278 patients with sPAP at rest > 35 mmHg met inclusion criteria. One patient was lost to follow-up. Mean age of patients was 72 ± 10 years, 178 (64%) of the study population were men. There were no relevant differences among survivors and non-survivors concerning comorbidities. Exercise performance (3.6 ± 1.2 vs. 4.9 ± 1.4 MET, p < 0.001) was lower, whereas sPAP during exercise was higher (67.3 ± 14.7 vs. 62.1 ± 13.2 mmHg, p = 0.027) in non-survivors. Univariate predictors of all-cause mortality were NYHA functional class III (HR = 2.56, p < 0.001), ≥ 2-vessels coronary artery disease (CAD) (HR = 1.93, p = 0.04), left atrial diameter > 45 mm (HR = 2.58, p < 0.001), rest sPAP > 42 mmHg (HR = 1.94, p = 0.010) and ΔsPAP increase ≥ 0.23 mmHg/Watt (HF = 1.92, p = 0.010). After multivariate analysis, NYHA functional class III (HR = 2.35, p < 0.001), LA diameter (HR = 2.28, p = 0.003) and sPAP increase ≥ 0.23 mmHg/Watt (HF = 2.19, p = 0.002) remained significant predictors of mortality, whereas a double product (HR = 0.42, p = 0.005) was associated with better prognosis. sPAP assessment during routine EDE provides relevant prognostic information comparable to findings in studies in selected populations. A higher sPAP increase at lower exercise performance shows significant association with increased of mortality.
肺动脉高压是疾病严重程度的一个指标。运动多普勒超声心动图(EDE)已被证明在评估肺动脉压力方面是可行且可靠的。在对照研究中,收缩期肺动脉压(sPAP)升高具有诊断和预后价值。然而,在心肺疾病患者的常规检查中,当静息sPAP>35 mmHg时评估其价值尚不明确。对有EDE适当临床指征患者的数字存储EDE检查进行临床记录和离线重新评估。N = 278例静息sPAP>35 mmHg的患者符合纳入标准。1例患者失访。患者的平均年龄为72±10岁,研究人群中178例(64%)为男性。在合并症方面,幸存者和非幸存者之间没有相关差异。非幸存者的运动能力较低(3.6±1.2 vs. 4.9±1.4代谢当量,p<0.001),而运动期间的sPAP较高(67.3±14.7 vs. 62.1±13.2 mmHg,p = 0.027)。全因死亡率的单变量预测因素为纽约心脏协会(NYHA)功能分级III级(HR = 2.56,p<0.001)、≥2支血管的冠状动脉疾病(CAD)(HR = 1.93,p = 0.04)、左心房直径>45 mm(HR = 2.58,p<0.001)、静息sPAP>42 mmHg(HR = 1.94,p = 0.010)以及ΔsPAP升高≥0.23 mmHg/瓦(HF = 1.92,p = 0.010)。多变量分析后,NYHA功能分级III级(HR = 2.35,p<0.001)、左心房直径(HR = 2.28,p = 0.003)和sPAP升高≥0.23 mmHg/瓦(HF = 2.19,p = 0.002)仍然是死亡率的显著预测因素,而双乘积(HR = 0.42,p = 0.005)与较好的预后相关。常规EDE期间的sPAP评估提供了与特定人群研究结果相当的相关预后信息。在较低运动能力时sPAP升高较高与死亡率增加显著相关。